Pubblicazioni ufficiali Innate Pharma

Azioni

Tempo reale Euronext Paris Altri mercati azionari 15:11:07 05/06/2024			Variaz. 5gg	Var. 1 gen.
2,53 ^EUR	-2,50%		-1,17%	-3,44%

04/06	Innate Pharma SA presenta i risultati positivi dello studio di Fase 2 TELLOMAK con lacutamab nella micosi fungoide	CI
14/05	Transcript : Innate Pharma S.A., Q1 2024 Earnings Call, May 14, 2024

3rd quarter results	14/11/22	CO
Threshold crossings	21/10/22	CO
Provisional calendar	20/10/22	CO
Provisional calendar	20/10/22	CO
Slide show half-year results	15/09/22	CO
1st-half-year results	15/09/22	CO
1st-half-year results	15/09/22	CO
Half-year report	15/09/22	CO
Half-year report	15/09/22	CO
Monthly statement on voting rights	31/07/22	CO
Monthly statement on voting rights	31/07/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	28/07/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	28/07/22	CO
Threshold crossings	18/07/22	CO
Corporate officers' Statement : Sale	29/06/22	CO
Corporate officers' Statement : Sale	17/06/22	CO
Corporate officers' Statement : Sale	14/06/22	CO
Corporate officers' Statement : Sale	14/06/22	CO
Corporate officers' Statement : Sale	14/06/22	CO
Slide show Q1	10/05/22	CO
1st quarter turnover	10/05/22	CO
1st quarter turnover	10/05/22	CO
Monthly statement on voting rights	30/04/22	CO
Monthly statement on voting rights	30/04/22	CO
Monthly statement on voting rights	28/02/22	CO